摘要:
A GPR7 ligand containing the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO:1 wherein the N-terminal amino acid residue may optionally be brominated, is useful in developing a receptor-binding assay system with the use of the GPR7 expression system, in screening a candidate compound for a drug such as an antiobestic, etc.
摘要翻译:含有与SEQ ID NO:1所示的氨基酸序列相同或基本上相同的氨基酸序列的GPR7配体,其中N-末端氨基酸残基可任选被溴化,可用于开发受体结合测定系统,其中 使用GPR7表达系统,筛选候选化合物用于药物如抗生物等。
摘要:
The present invention provides a method of screening an agonist or antagonist to a G protein-coupled receptor protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, which comprises using the receptor protein or a salt thereof and the ligand or a salt thereof; etc. The present invention is useful for screening agents for the prevention/treatment of, e.g., leukopenia, leukemia, lymphoma, malignant tumor, ulcerative colitis, rheumatoid arthritis, inflammatory bowel disorders, tonsil disorders, collagen disease, inflammatory disease, leukocytosis, heart failure, inherited muscle disorders, muscular dystrophy, neuromuscular degenerative disease, myocardial infarction, obesity, mellitus diabetes, hyperlipemia, arteriosclerosis, metabolic syndrome, thrombocytopenia, thrombocytosis, cancer, pulmonary edema, multiple organ failure, etc.
摘要翻译:本发明提供筛选G蛋白偶联受体蛋白的激动剂或拮抗剂的方法,其包含与SEQ ID NO:1所示的氨基酸序列相同或基本上相同的氨基酸序列,或其盐,其包含 使用受体蛋白或其盐和配体或其盐; 本发明可用于预防/治疗例如白细胞减少症,白血病,淋巴瘤,恶性肿瘤,溃疡性结肠炎,类风湿性关节炎,炎性肠病,扁桃体病,胶原病,炎性疾病,白细胞增多症,心脏病 失败,遗传性肌肉疾病,肌营养不良症,神经肌肉退行性疾病,心肌梗死,肥胖症,糖尿病,高脂血症,动脉硬化,代谢综合征,血小板减少症,血小板增多症,癌症,肺水肿,多器官衰竭等。
摘要:
The present invention provides a method of screening an agonist or antagonist to a G protein-coupled receptor protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, which comprises using the receptor protein or a salt thereof and the ligand or a salt thereof; etc. The present invention is useful for screening agents for the prevention/treatment of, e.g., leukopenia, leukemia, lymphoma, malignant tumor, ulcerative colitis, rheumatoid arthritis, inflammatory bowel disorders, tonsil disorders, collagen disease, inflammatory disease, leukocytosis, heart failure, inherited muscle disorders, muscular dystrophy, neuromuscular degenerative disease, myocardial infarction, obesity, mellitus diabetes, hyperlipemia, arteriosclerosis, metabolic syndrome, thrombocytopenia, thrombocytosis, cancer, pulmonary edema, multiple organ failure, etc.
摘要翻译:本发明提供筛选G蛋白偶联受体蛋白的激动剂或拮抗剂的方法,其包含与SEQ ID NO:1所示的氨基酸序列相同或基本上相同的氨基酸序列,或其盐,其包含 使用受体蛋白或其盐和配体或其盐; 本发明可用于预防/治疗例如白细胞减少症,白血病,淋巴瘤,恶性肿瘤,溃疡性结肠炎,类风湿性关节炎,炎性肠病,扁桃体病,胶原病,炎性疾病,白细胞增多症,心脏病 失败,遗传性肌肉疾病,肌营养不良症,神经肌肉退行性疾病,心肌梗死,肥胖症,糖尿病,高脂血症,动脉硬化,代谢综合征,血小板减少症,血小板增多症,癌症,肺水肿,多器官衰竭等。
摘要:
The present invention relates to screening of an agonist/antagonist, etc. Specifically, the present invention provides a method of screening an agonist or antagonist of a G protein-coupled receptor protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, which comprises using the receptor protein or a salt thereof and a cholesterol metabolism-related substance, and so on.
摘要翻译:本发明涉及激动剂/拮抗剂等的筛选。具体而言,本发明提供筛选G蛋白偶联受体蛋白的激动剂或拮抗剂的方法,其包含与氨基酸相同或基本上相同的氨基酸序列 由SEQ ID NO:1表示的序列或其盐,其包括使用受体蛋白质或其盐和胆固醇代谢相关物质等。
摘要:
The present invention relates to screening of an agonist/antagonist, etc. Specifically, the present invention provides a method of screening an agonist or antagonist of a G protein-coupled receptor protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, which comprises using the receptor protein or a salt thereof and a cholesterol metabolism-related substance, and so on.
摘要翻译:本发明涉及激动剂/拮抗剂等的筛选。具体而言,本发明提供筛选G蛋白偶联受体蛋白的激动剂或拮抗剂的方法,其包含与氨基酸相同或基本上相同的氨基酸序列 由SEQ ID NO:1表示的序列或其盐,其包括使用受体蛋白质或其盐和胆固醇代谢相关物质等。
摘要:
An exhalation collected in a breath bag capable of expanding and contracting is sucked into a gas inlet vessel 21 with a given volume (Va), and then the gas inlet vessel 21 is communicated by means of valve V2 with a cell 11 that is maintained at an atmospheric pressure by being pre-filled with a sample gas or reference gas. After the communication, the gas pressure is measured by a pressure sensor 16 attached to the cell 11. Whether the exhalation collected in the breath bag is below a given amount or not can be accurately judged.
摘要:
The present invention provides a medicament for preventing/treating cancer, comprising a tacrine compound, or a compound promoting the binding between the tacrine compound and a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1.
摘要翻译:本发明提供了用于预防/治疗癌症的药物,其包含他克林化合物或促进他克林化合物与包含与SEQ ID NO所示氨基酸序列相同或基本相同的氨基酸序列的蛋白质之间的结合的化合物 :1。
摘要:
Provided is a filter medium including a porous polytetrafluoroethylene (PTFE) membrane and a gas-permeable supporting member that are integrated to ensure sufficient stiffness, having excellent gas permeability, and providing excellent bonding between respective layers included in the filter medium. The gas-permeable supporting member includes: a substrate having gas-permeability; and a fiber layer that is placed on the substrate so as to be in contact with the porous PTFE membrane. The gas-permeable supporting member has a structure in which fibers of the fiber layer enter into the substrate and are entangled with the substrate so that the fiber layer is bonded to the substrate. The fiber layer contains polyolefin-containing fibers that are bonded to the porous membrane.
摘要:
An exhalation collected in a breath bag capable of expanding and contracting is sucked into a gas inlet vessel 21 with a given volume (Va), and then the gas inlet vessel 21 is communicated by means of valve V2 with a cell 11 that is maintained at an atmospheric pressure by being pre-filled with a sample gas or reference gas. After the communication, the gas pressure is measured by a pressure sensor 16 attached to the cell 11. Whether the exhalation collected in the breath bag is below a given amount or not can be accurately judged.
摘要:
The present invention aims at providing a novel polypeptide, a receptor, a DNA thereof, and the like. Specifically, the present invention provides a polypeptide having a binding ability to the protein represented by SEQ ID NO: 1 or SEQ ID NO: 3, or its amide, its ester or its salt, a polynucleotide encoding the polypeptide, an antisense polynucleotide or an antibody to the polypeptide, a screening of agent for prevention and/or treatment of cancer, obesity, etc., which comprises using the above, and the like.The polypeptide, receptor, polynucleotide, antisense polynucleotide, antibody and the like are useful for an agent of prevention and/or treatment of cancer, obesity and the like. Further, they are useful for a screening of an agent for prevention and/or treatment of cancer, obesity and the like.
摘要翻译:本发明的目的在于提供新的多肽,受体及其DNA等。 具体地说,本发明提供了具有与SEQ ID NO:1或SEQ ID NO:3所代表的蛋白结合能力的多肽或其酰胺,其酯或其盐,编码多肽的多核苷酸,反义多核苷酸或 对多肽的抗体,筛选用于预防和/或治疗癌症,肥胖症等的药剂,其包括使用上述方法等。 多肽,受体,多核苷酸,反义多核苷酸,抗体等可用于预防和/或治疗癌症,肥胖症等。 此外,它们可用于筛选用于预防和/或治疗癌症,肥胖症等的药剂。